Seely Lynn 4
4 · Lyell Immunopharma, Inc. · Filed Oct 29, 2025
Insider Transaction Report
Form 4
Seely Lynn
DirectorPresident and CEO
Transactions
- Award
Option (right to buy)
2025-10-27+175,000→ 175,000 totalExercise: $17.23Exp: 2035-10-26→ Common Stock (175,000 underlying)
Holdings
- 67,571
Common Stock
Footnotes (1)
- [F1]12.5% of the option shares will vest on April 27, 2026, with the remaining option shares to vest in equal monthly installments over the following forty-two months, subject to the reporting person providing service through the applicable vesting date.